Skip to main content Skip to main navigation
Government logo | to homepage of National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Nederlands
  • English
  • Home
  • News

News


Search

Fill in your search phrase.

Topics

  • (-) HPV vaccination (12)
  • International (233)
  • COVID-19 vaccination (158)
  • COVID-19 (141)
  • National Immunisation Programme (20)
  • Antimicrobial resistance (19)
  • Immunisation and vaccination (16)
  • Tobacco (16)
  • Circular economy (15)
  • COVID-19 (14)
  • Zoonotic diseases (14)
  • Air (13)
  • Heat (13)
  • Flu and flu vaccine (11)
  • Healthy living environment (11)
  • Nanotechnology (11)
  • One Health (11)
  • WHO Collaborating Centre Antimicrobial Resistance Epidemiology and Surveillance (11)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (11)
  • Ebola (10)
  • WHO Collaborating for Centre Risk Assessment of Pathogens in Food and Water (10)
  • Food safety (9)
  • Microplastics (9)
  • Medical devices (8)
  • Nitrogen (8)
  • Measles (7)
  • Sexually transmitted infections (STIs) (7)
  • Sustainable Development Goals (7)
  • Tuberculosis (7)
  • WHO Collaborating Centre on Chemical Food Safety (7)
  • Health research for COVID-19 (6)
  • Mpox (6)
  • PFAS (6)
  • Public Health Foresight (6)
  • Salmonella (6)
  • Soil and water (6)
  • Sustainability (6)
  • Food and Nutrition (5)
  • MERS-coronavirus (5)
  • Population screening programmes (5)
  • Tick-borne encephalitis (5)
  • Accidents and disasters (4)
  • Biobased economy (4)
  • Bisphenol A (BPA) (4)
  • Food Reformulation (4)
  • Hydrofluorocarbons (4)
  • Rubber granulate (4)
  • WHO Collaborating Centre for Nutrition (4)
  • Chromium (VI) and CARC (3)
  • Climate change and Health (3)
  • ConsExpo (3)
  • Dutch National Food Consumption Survey (3)
  • Heel prick (3)
  • Legionnaires' disease (Legionellosis) (3)
  • Meningococcal ACWY (3)
  • Mosquitos (3)
  • Occupational Safety (3)
  • Pharmaceuticals in the environment (3)
  • Replacement, reduction, refinement of animal use (3Rs) (3)
  • West Nile fever (3)
  • Assistance RIVM Sint Maarten landfill (2)
  • CAESAR (2)
  • Cervical cancer screening programme (2)
  • Consumer exposure to chemical substances (2)
  • Dutch Food Composition Database (NEVO) (2)
  • International projects (2)
  • Population screening programmes in the Caribbean Netherlands (2)
  • RSV (2)
  • UV ozone layer and climate (2)
  • Beeldschermgebruik (1)
  • Breast Cancer Screening Programme (1)
  • Chikungunya (1)
  • Chikungunya (1)
  • Chroom-6 (1)
  • Dengue (1)
  • E-health (digitale zorg) (1)
  • GenX (1)
  • Health promotion (1)
  • HPV - Humaan Papillomavirus (1)
  • Leefstijlmonitor (1)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (1)
  • Perinatal screening (1)
  • PFAS (1)
  • PFOA (1)
  • Physical Activity (1)
  • Pneumococci (1)
  • Polio (1)
  • Radiation exposure in the Netherlands (1)
  • Rotavirus (1)
  • Sustainable procurement (1)
  • Synthetic biology (1)
  • Veilige leefomgeving (1)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (1)
  • WHO Collaborating Centre on Life Course and Health (1)
  • Zika Virus (1)

Publication date

  • January 2023 (1)
  • September 2022 (1)
  • January 2022 (1)
  • September 2019 (1)
  • September 2018 (1)
  • June 2018 (1)
  • January 2015 (1)
  • November 2014 (1)
  • April 2014 (1)
  • February 2014 (1)
  • January 2014 (1)
  • June 2013 (1)

More than two million invitations to get vaccinated against HPV in 2023

In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
01/11/2023 - 14:00

Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity

This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.

09/01/2022 - 13:52
Campagnefoto HPV. In beeld staan 3 jongenren met tekst: Met 1 vaccin beschermd tegen 6 soorten kanker

RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine

Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
01/31/2022 - 14:58
Jongen en meisjes poseren op een kruk voor campagneposter HPV vaccin

State Secretary Blokhuis: boys will also be vaccinated against HPV virus

The vaccine against the HPV human papillomavirus virus will also become available for boys.

09/30/2019 - 09:38

Research: HPV vaccine is safe

RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.

09/24/2018 - 00:00

Vaccination rate again drops slightly, HPV vaccination rate drops considerably

The vaccination rate for vaccines included in the National Immunisation Programme has dropped slightly by about 1 percent.

06/25/2018 - 00:00

RIVM and Olive Foundation open trading to mark the European Cervical Cancer Prevention Week

January 20th, the Olive Foundation and RIVM opened AEX trading day in Amsterdam on the occasion of the 9th European Cervical Cancer Prevention Week.

01/20/2015 - 00:00

The National Immunisation Programme in the Netherlands 2013 - 2014

Every year, RIVM provides an overview of surveillance and developments in the National Immunisation Programme (NIP).

11/11/2014 - 00:00

Increasing number of girls immunised against HPV

In 2014 the number of girls who were immunised against the human papilloma virus (HPV) rose. This virus can cause cervical cancer later in life.

04/24/2014 - 00:00

The National Immunisation Programme in the Netherlands: Developments in 2013

Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).

02/05/2014 - 00:00

Pagination

  • Current page 1
  • Page 2
  • › Next ›
  • » Last »

Share this page


  • Facebook
  • Twitter
  • LinkedIn
  • WhatsApp
  • Email

Service

  • Contact
  • Working for RIVM
  • Information for the press
  • RIVM Newsletters
  • RSS feed
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow us on LinkedIn
  • Follow us on YouTube
  • Follow us on Instagram

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Submitting WOO requests to RIVM
  • Copyright
  • Archive

Languages

  • English
  • Nederlands